Article Text

Download PDFPDF
Expression of p53, c-erbB-2, Ki-67, and CD34 in granulosa cell tumor of the ovary
  1. S. Kusamura*,
  2. S. Derchain*,
  3. M. Alvarenga*,
  4. C. P. Gomes,
  5. K. J. Syrjänen and
  6. L. A. L. A. Andrade
  1. * Department of Obstetrics and Gynecology, School of Medical Science, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
  2. Department of Pathology, School of Medical Science, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
  3. Department of Cytopathology Unit, Laboratory of Epidemiology and Biostatistics, National Institute of Health (ISS) Rome, Italy.
  1. Address correspondence and reprint requests to: Sophie Derchain, Rua Dr António Hossri, 629, 13083–370, Campinas, SP, Brazil. Email: derchain{at}


The purpose of this study is to investigate the expression of p53, c-erbB-2, Ki-67, and angiogenic activity and their correlation with the clinicopathologic characteristics in a series of granulosa cell tumors of the ovary (GCTO). Eighteen GCTO cases assisted at the Department of Obstetrics and Gynecology, School of Medical Science, UNICAMP, after diagnostic confirmation by three pathologists, were submitted to immunohistochemistry for assessment of p53, c-erbB-2, Ki-67, and CD34 expressions. The mean tumor size was 13 cm (range: 4–30 cm). Six (33%) cases presented with extraovarian disease. Thirteen (72%) cases presented some solid diffuse or sarcomatoid pattern and six (33%) moderate or strong atypia. Fourteen cases presented ≤2 mitoses/10 HPF. Thirteen cases were focally positive for Ki-67. The mean Ki-67 proliferative index was 1.0%. One case presented positive expression for mutant p53 but all cases were negative for c-erbB-2 expression. The mean microvascular density was 28.9/mm2 (range: 0–50). No significant correlations could be established between the biologic markers and clinicopathologic variables. GCTO showed a markedly low rate of immunohistochemical staining for p53 or c-erbB-2 overexpression/amplification, as well as low proliferative and angiogenic activities. Further studies are urgently needed to elaborate the factors responsible for the highly unpredictable clinical course of GCTO.

  • biologic markers
  • immunohistochemistry
  • ovarian granulosa cell tumor

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • This study was supported in part by FAPESP grants n°00/09504-1 and CNPq n°300354/01.